Gulu University to conduct COVID-19 herbal medicine clinical trials :: Uganda Radionetwork

0


Speaking to MPs on the Covid-19 task force, Dr Lamwaka said they were set to conduct clinical trials with protocols designed as a result of the positive response from those who have used the drug. She says, however, that they need funding to conduct clinical trials.

Gulu University has said it is ready to conduct a clinical study on Covilyce-1, a herbal medicine.

A clinical trial is a stage where experiments are conducted with a health intervention to obtain sufficient evidence for a process considered effective as a medical treatment.

Three weeks ago, a group of more than ten scientists at the University began packaging four different concoctions that they were said to be administering to covid-19 patients in the community since January 2021. University scientists led by Dr Alice Veronica Lamwaka announced that 100 Covid-19 patients who used Covilyce-1 have recovered.

On Tuesday, the National Drug Authority (NDA) ordered Gulu University to cease production of Covilyce-1, saying it has not yet been approved.

However, on Thursday, President Museveni, during a meeting with a team of scientists from Gulu University, gave the green light to the University to continue development of the herbal drug.

Speaking to MPs on the Covid-19 task force, Dr Lamwaka said they were set to conduct clinical trials with protocols designed as a result of the positive response from those who have used the drug. She says, however, that they need funding to conduct clinical trials.

// Cue in: “covilyce-1

Attention: “local remedies.//

According to Lamwaka, the study results will help them set up a traditional medicine hospital in northern Uganda alongside modern systems. She also requested support from the Pharmaceutical Society of Uganda.

“This is a unique research experience that is difficult to cover and keep underground, especially when there is evidence of a full and massive recovery of clients, coupled with a dramatic reduction in the rate of infection in the Acholi sub-region where the formulations were made, ”she said. said.

Bar-Dege Layibi MP Martin Ojara Mapenduzi called on various scientists, Ugandans and government agencies, among others, to support the university’s initiative.

Jonam County MP Emmanuel Ongiertho said parliament should allocate more funds for research at other universities, as has been done for Makerere University.

“It makes other universities believe that they are inferior in research, so we will make sure within the education committee to advocate for universities to get their share of research funds,” Ongiertho said.

NDA spokesperson Abias Rwamwiri said every step in the development of a drug is essential.

“If it is to undertake a clinical trial, the NDA will be involved as we are mandated to approve and oversee clinical trials to be undertaken in Uganda,” Rwamwiri said.

The NDA evaluates the clinical trial application, including the clinical research protocol which has been approved by an accredited research ethics board and approved by the Uganda National Council for Science and Technology before being submitted to the NDA.

In public health emergencies, if there is a need to expedite the process, a mechanism for joint review by all relevant regulatory bodies has been established and is coordinated by the Uganda National Council for Science and Technology .



Share.

Leave A Reply